Private Advisor Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-28,000
| Closed | -$6.91K | – | 2862 |
|
|
2026
Q1 | $6.91K | Hold |
28,000
| – | – | ﹤0.01% | 2652 |
|
|
2025
Q4 | $11.8K | Hold |
28,000
| – | – | ﹤0.01% | 2565 |
|
|
2025
Q3 | $18.9K | Hold |
28,000
| – | – | ﹤0.01% | 2496 |
|
|
2025
Q2 | $15.2K | Buy |
+28,000
| New | +$16.6K | ﹤0.01% | 2407 |
|
|
2022
Q3 | – | Sell |
-12,631
| Closed | -$52K | – | 2100 |
|
|
2022
Q2 | $52K | Buy |
+12,631
| New | +$54.6K | ﹤0.01% | 2005 |
|
|
2022
Q1 | – | Sell |
-11,766
| Closed | -$89K | – | 2262 |
|
|
2021
Q4 | $89K | Sell |
11,766
-18,284
| -61% | -$159K | ﹤0.01% | 2037 |
|
|
2021
Q3 | $271K | Buy |
30,050
+11,252
| +60% | +$111K | ﹤0.01% | 1749 |
|
|
2021
Q2 | $225K | Sell |
18,798
-123
| -0.7% | -$1.39K | ﹤0.01% | 1773 |
|
|
2021
Q1 | $237K | Sell |
18,921
-3,131
| -14% | -$42.2K | ﹤0.01% | 1659 |
|
|
2020
Q4 | $344K | Buy |
+22,052
| New | +$258K | ﹤0.01% | 1405 |
|
|
2020
Q3 | – | Sell |
-6,200
| Closed | -$56K | – | 3111 |
|
|
2020
Q2 | $56K | Buy |
+6,200
| New | +$57.5K | ﹤0.01% | 2038 |
|
|
2019
Q1 | – | Sell |
-20,300
| Closed | -$233K | – | 1595 |
|
|
2018
Q4 | $233K | Buy |
20,300
+5,842
| +40% | +$72.6K | 0.01% | 1134 |
|
|
2018
Q3 | $245K | Buy |
+14,458
| New | +$220K | 0.01% | 1333 |
|
|
2014
Q2 | – | Sell |
-23,054
| Closed | -$417K | – | 961 |
|
|
2014
Q1 | $417K | Buy |
+23,054
| New | +$444K | 0.04% | 470 |
|
Other funds holding SGMO
Private Advisor Group's SGMO Position: Q2 2026 in Review
Private Advisor Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 28,000 shares — an estimated $6.91K sold.
Private Advisor Group first reported a position in SGMO in Q1 2014 and held it in 14 quarters. The position peaked at $417K in Q1 2014. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.
- Private Advisor Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
- Private Advisor Group sold 28,000 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $6.91K.
- Private Advisor Group first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 14 quarters.
- Private Advisor Group's SANGAMO THERAPEUTICS INC position peaked at $417K in Q1 2014.
- 2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.
Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.